Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Social Cognition in Schizophrenia
NCT00884897Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2010
- Primary completion
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Oxytocin with Placebo (2 arms). Primary endpoints: Mayer-Salovey-Caruso Emotional Intelligence Test at 3 weeks and Maryland Assessment of Social Competence at 3 weeks. Started Jan 2010; status: completed.
02
Drugs
oxytocin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00884897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884897.